Top Page
Spectris
(LSE:SXS)
Spectris (SXS) vs. iShares MSCI United Kingdom ETF (EWC)
Spectris Business Overview & Revenue Model
Spectris Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.34B | 1.30B | 1.45B | 1.33B | 1.16B | 1.34B |
| Gross Profit | 687.70M | 715.90M | 813.20M | 730.00M | 652.20M | 698.00M |
| EBITDA | 180.70M | 381.40M | 247.20M | 214.70M | 430.00M | 98.30M |
| Net Income | 57.80M | 233.20M | 145.40M | 125.00M | 346.90M | -17.00M |
Balance Sheet | ||||||
| Total Assets | 2.44B | 2.56B | 1.82B | 1.95B | 1.77B | 1.80B |
| Cash, Cash Equivalents and Short-Term Investments | 87.40M | 105.70M | 138.50M | 228.10M | 167.80M | 222.20M |
| Total Debt | 709.60M | 731.40M | 62.70M | 65.20M | 65.90M | 156.50M |
| Total Liabilities | 1.14B | 1.18B | 501.80M | 511.10M | 506.80M | 576.50M |
| Stockholders Equity | 1.31B | 1.38B | 1.32B | 1.44B | 1.26B | 1.22B |
Cash Flow | ||||||
| Free Cash Flow | 57.20M | 41.50M | 170.50M | 75.60M | 121.20M | 178.40M |
| Operating Cash Flow | 114.20M | 93.20M | 195.20M | 120.50M | 156.50M | 221.50M |
| Investing Cash Flow | -808.70M | -548.00M | -70.20M | 216.30M | 201.30M | -44.30M |
| Financing Cash Flow | 504.40M | 439.10M | -210.70M | -286.40M | -394.60M | -180.10M |
Spectris Technical Analysis
Spectris Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £572.09M | 22.18 | 8.49% | 2.12% | 0.49% | 61.73% | |
74 Outperform | £2.49B | 29.66 | 9.15% | 2.16% | 3.15% | -13.57% | |
69 Neutral | £379.11M | 34.43 | 12.24% | 1.89% | 5.46% | -26.44% | |
67 Neutral | £170.27M | 45.86 | 3.13% | 2.11% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | £4.11B | 70.78 | 4.26% | 2.04% | 0.07% | -78.33% | |
54 Neutral | £202.39M | -2.84 | -31.42% | ― | -16.33% | -448.12% |
Spectris Corporate Events
Spectris plc, a company involved in precision instrumentation and controls, announced several share transactions involving its executives. Chief Executive Andrew Heath sold 70,000 shares and, along with Rachel Heath, transferred 7,900 shares each to The Heath Family 2025 Trust. Additionally, Derek Harding, President of Spectris Scientific, gifted 2,433 shares to a charity and sold a total of 12,567 shares. These transactions reflect internal financial maneuvers and charitable contributions, potentially impacting stakeholder perceptions and the company’s market positioning.
Spectris plc, a company involved in the issuance of ordinary shares, has announced an update regarding its total voting rights and capital as of November 30, 2025. The company has 104,446,214 ordinary shares with voting rights and 5,034,079 shares held in treasury, resulting in a total of 99,412,135 voting rights. This information is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules.
Spectris PLC has announced an update regarding its acquisition by Project Aurora Bidco Limited, a special purpose vehicle owned by investment funds advised by Kohlberg Kravis Roberts & Co. L.P. (KKR). The acquisition, valued at £41.75 per share, is being executed through a court-sanctioned scheme of arrangement and has received necessary antitrust and regulatory approvals from authorities in France, the Netherlands, and Spain. The scheme is expected to become effective on 4 December 2025, with trading of Spectris shares on the London Stock Exchange to be suspended from 7.30 a.m. on that date. The acquisition marks a significant development in Spectris’ corporate trajectory, potentially impacting its market positioning and shareholder value.
Spectris plc has announced a change in its board, with Nick Anderson, a Non-executive Director at Spectris, being appointed as a Non-executive Director and future Chair of Hill & Smith PLC, a company listed on the London Stock Exchange. This appointment signifies a strategic move for Spectris, potentially enhancing its influence and connections within the industry, which may impact its market positioning and stakeholder relations.
Spectris plc announced that Alison Henwood, a Non-executive Director, acquired 13 ordinary shares through a dividend reinvestment plan. This transaction, conducted on the London Stock Exchange, reflects the company’s ongoing commitment to shareholder engagement and may influence investor confidence in the company’s governance practices.
Spectris plc has announced the acquisition of shares under its Share Incentive Plan (SIP) by individuals with managerial responsibilities. On November 7, 2025, a total of nine ordinary shares were purchased for these individuals, with one additional matching share awarded for every five shares purchased. This initiative is part of an HMRC tax-advantaged all-employee share plan, reflecting Spectris’s commitment to employee investment and engagement. The transactions were conducted on the London Stock Exchange, and the move is expected to further align the interests of the company’s management with those of its shareholders.
Spectris plc announced the acquisition of shares under its Share Incentive Plan (SIP) by key managerial personnel following the reinvestment of dividends. This transaction, involving the purchase of a total of 9 ordinary shares, reflects the company’s commitment to aligning management interests with shareholder value, potentially strengthening its market position and stakeholder confidence.
Spectris plc has announced that Dr. Ravi Gopinath, an Independent Non-Executive Director of the company, has been appointed as an independent director of Neuland Laboratories, which is listed on the National Stock Exchange of India and the Bombay Stock Exchange. This appointment may enhance Spectris’s strategic connections and influence within the global market, potentially impacting its operations and industry positioning positively.
Spectris plc, a company involved in the manufacturing sector, has announced an update regarding its total voting rights and share capital as of October 31, 2025. The company has issued 104,446,214 ordinary shares with voting rights, with 5,036,896 shares held in treasury, resulting in a total of 99,409,318 voting rights. This update is crucial for shareholders to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
In the third quarter of 2025, Spectris reported a significant increase in sales, with group sales rising by 11% on a reported basis and 4% on a like-for-like basis compared to the previous year. The company remains optimistic about meeting its full-year adjusted operating profit expectations and is progressing with the acquisition by KKR, which is in advanced stages of preparation.
Spectris plc, a company involved in precision instrumentation and controls, has reported share transactions involving its executive directors. Andrew Heath and Derek Harding, both Executive Directors at Spectris, have transferred 10,000 and 15,000 shares respectively to closely associated persons for nil consideration. These transactions, conducted outside a trading venue, are part of routine disclosures under the Market Abuse Regulation.
Spectris plc has announced the acquisition of Partnership Shares and the award of Matching Shares under its Share Incentive Plan (SIP) for persons discharging managerial responsibilities (PDMRs). This move, compliant with EU Market Abuse Regulation, involved purchasing 12 ordinary shares and awarding 2 matching shares to PDMRs at no cost. This initiative reflects Spectris’s commitment to employee investment and aligns with its strategy to incentivize management, potentially impacting stakeholder confidence positively.
Spectris plc, a company listed on the stock market, has announced an update on its total voting rights and share capital as of September 30, 2025. The company has 104,446,214 ordinary shares with voting rights and 5,037,091 shares held in treasury, resulting in a total of 99,409,123 voting rights. This information is crucial for shareholders to determine their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules.
Spectris PLC, a leader in precision instrumentation and controls, is set to be acquired by Project Aurora Bidco Limited, a special purpose vehicle owned by investment funds advised by Kohlberg Kravis Roberts & Co. L.P. The acquisition has received necessary clearances from the European Commission and FDI authorities in Austria and Belgium, with the transaction expected to complete by Q1 2026, subject to remaining conditions. This acquisition is anticipated to enhance Spectris’ market positioning and operational capabilities.
Spectris PLC, a company involved in a recommended cash acquisition by Project Aurora Bidco Limited, has announced the expiration of the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976 for the acquisition. Additionally, foreign direct investment authorities in Denmark and Germany have granted clearance under applicable FDI laws, indicating progress in the acquisition process. The scheme is expected to become effective by Q1 2026, pending satisfaction of remaining conditions.
Spectris plc announced the acquisition and award of shares under its Share Incentive Plan (SIP) for its managerial staff, in compliance with the EU Market Abuse Regulation. This move, involving the purchase of Partnership Shares and the award of Matching Shares, reflects the company’s commitment to employee investment and aligns with its strategic goals, potentially enhancing stakeholder confidence and employee engagement.
Spectris PLC, a company involved in a recommended cash acquisition by Project Aurora Bidco Limited, has announced regulatory clearance for the acquisition from both the State Administration for Market Regulation of China and the Italian foreign direct investment authority. The acquisition process is progressing as expected, with the scheme anticipated to become effective by the first quarter of 2026, pending the satisfaction of remaining conditions.